Adage Capital Partners’s Edgewise Therapeutics EWTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-390,000
| Closed | -$8.58M | – | 882 |
|
|
2025
Q1 | $8.58M | Buy |
390,000
+150,000
| +63% | +$3.3M | 0.02% | 615 |
|
|
2024
Q4 | $6.41M | Buy |
240,000
+218,491
| +1,016% | +$5.83M | 0.01% | 686 |
|
|
2024
Q3 | $574K | Sell |
21,509
-28,088
| -57% | -$750K | ﹤0.01% | 810 |
|
|
2024
Q2 | $893K | Buy |
+49,597
| New | +$893K | ﹤0.01% | 806 |
|
|
2021
Q2 | – | Sell |
-300,000
| Closed | -$9.75M | – | 1030 |
|
|
2021
Q1 | $9.75M | Buy |
+300,000
| New | +$9.75M | 0.02% | 687 |
|